Fabrication of Carboxymethyl Chitosan Nanoparticles to Deliver Paclitaxel for Melanoma Treatment
- 25 May 2020
- journal article
- research article
- Published by Wiley in Chemnanomat
- Vol. 6 (9) , 1373-1385
Abstract
In the present study, the effectiveness of paclitaxel nanocrystals (PTX NCs) encapsulated in carboxymethyl chitosan (CMCS) nanoparticles (CMCS−PTX NPs) as an anticancer drug is evaluated. The CMCS nanoparticles are produced via a cross‐junction microfluidic device where the PTX/CMCS concentration and flow rates in the device are optimized. The dynamic light scattering data show that the PTX NCs have a median diameter size of 230±90 nm, while the size of CMCS−PTX NPs is roughly 270±30 nm. The zeta‐potential result indicates less negative surface charge for the CMCS−PTX NPs as compared to the PTX NCs. Moreover, scanning electron microscopy micrographs, differential scanning calorimetry thermograms, and X‐ray diffraction patterns reveal that the physicochemical properties of the drug remain unaltered after perfusion through the microfluidic device. Cytotoxicity and cell endocytosis of PTX NCs and CMCS−PTX NPs are evaluated in vitro using G361 melanoma‐positive skin cells. The results reveal that the CMCS−PTX NPs increase the cellular uptake and cytotoxicity compared to the PTX NCs alone. In addition, the antitumor effect of CMCS−PTX NPs on B16 melanoma indicates the great potential of CMCS as a promising nano‐carrier for PTX NCs drug with potent inhibitory effect on the tumor growth.Keywords
This publication has 51 references indexed in Scilit:
- Non-invasive measurement of glucose uptake of skeletal muscle tissue models using a glucose nanobiosensorBiosensors and Bioelectronics, 2013
- Biochemical and Histological Study of Rat Liver and Kidney Injury Induced by CisplatinJournal of Toxicologic Pathology, 2013
- Complement activation by polyethoxylated pharmaceutical surfactants: Cremophor-EL, Tween-80 and Tween-20European Journal of Pharmaceutical Sciences, 2012
- Description of anaphylactic reactions to paclitaxel and docetaxel reported to the FDA, with a focus on the role of premedicationExpert Opinion on Drug Safety, 2011
- Nanosizing for oral and parenteral drug delivery: A perspective on formulating poorly-water soluble compounds using wet media milling technologyAdvanced Drug Delivery Reviews, 2011
- Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxelPhysical Chemistry Chemical Physics, 2011
- Novel carboxymethyl derivatives of chitin and chitosan materials and their biomedical applicationsProgress in Materials Science, 2010
- Analysis and stability study of temozolomide using capillary electrophoresisJournal of Chromatography B, 2010
- Fabrication of PLGA nanoparticles with a fluidic nanoprecipitation systemJournal of Nanobiotechnology, 2010
- Nanofibrous membranes from aqueous electrospinning of carboxymethyl chitosanNanotechnology, 2008